Point72 Middle East FZE »

Tango Therapeutics shares owned by Point72 Middle East FZE

Quarter-by-quarter ownership of Tango Therapeutics (TNGX) shares owned by Point72 Middle East FZE from 13F filings

Historical chart of Point72 Middle East FZE investment in Tango Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Tango Therapeutics held by Point72 Middle East FZE consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Tango Therapeutics by Point72 Middle East FZE

Quarter filed Position value Share count Share price at filing
2023-12-31 $340k 34k 9.90
2023-03-31 $14k 3.6k 3.95

More positions owned by Point72 Middle East FZE

Spdr S&p 500 Etf Tr Tr Unit Call Option (SPY)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Spdr Dow Jones Indl Average Ut Ser 1 Call Option (DIA)
General Motors Company (GM)
Eli Lilly & Co. (LLY)
Invesco Qqq Tr Unit Ser 1 Call Option (QQQ)
Caterpillar Call Option (CAT)
UnitedHealth (UNH)
Amazon (AMZN)
Jd.com Spon Adr Cl A (JD)
Lauder Estee Cos Cl A Call Option (EL)
Target Corporation Call Option (TGT)
At&t (T)
Analog Devices Call Option (ADI)
Synopsys (SNPS)

View all positions for Point72 Middle East FZE

Top funds holding Tango Therapeutics

Trv Gp Iv
EcoR1 Capital
Boxer Capital
Nextech Invest
Southpoint Capital Advisors
Vanguard Group
Deerfield Management Company
Casdin Capital
Perceptive Advisors
Soleus Capital Management
Baker Bros. Advisors
Arrowpoint Asset Management
Bessemer
Samsara BioCapital
Goldman Sachs Group

View all funds holding Tango Therapeutics